drugset / Trial / NCT06353477
Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option
Phase 2/3
Completed
240 enrolled
Eskisehir Osmangazi University
Abdi Ibrahim Ilac San. ve Tic A.S. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This randomized controlled study aims to evaluate the effectiveness and safety of the pharmaceutical extract EPs® 7630 from P.sidoides in treating hand, foot, and mouth disease in children. The study will investigate the impact of EPs® 7630 on the severity of the disease over a specific period and its effects on hospitalization rates and potential complications. This research aims to contribute to the treatment of hand, foot, and mouth disease in children.
Timeline
- Start
- 2019-06-01
- Primary completion
- 2022-06-01
- Completion
- 2023-01-01
Publications
- Background Miller GD, Tindall JP. Hand-foot-and-mouth disease. JAMA. 1968 Mar 4;203(10):827-30. No abstract available.
- Sutcu M, Kara M, Yildiz F, Kilic O, Tural Kara T, Akkoc G, Buyukcam A, Elmas Bozdemir S, Ozgur Gundeslioglu O, Gul D, Iseri Nepesov M, Kara A. Hand, foot, and mouth disease: could EPs(R) 7630 be a treatment option? A prospective randomized open-label multicenter clinical study. Front Pediatr. 2024 May 20;12:1274010. doi: 10.3389/fped.2024.1274010. eCollection 2024.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EPs® 7630 | Traditional medicine (herbal / TCM) | 10 unknown | Oral |
| Comparator | EPs® 7630 | Traditional medicine (herbal / TCM) | 20 unknown | Oral |
| Comparator | EPs® 7630 | Traditional medicine (herbal / TCM) | 30 unknown | Oral |